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Comparative genetic, proteomic 
and phosphoproteomic analysis 
of C. elegans embryos with a focus 
on ham-1/STOX and pig-1/MELK in 
dopaminergic neuron development
Sarah-Lena Offenburger  , Dalila Bensaddek  , Alejandro Brenes Murillo, Angus I. Lamond & 
Anton Gartner
Asymmetric cell divisions are required for cellular diversity and defects can lead to altered daughter 
cell fates and numbers. In a genetic screen for C. elegans mutants with defects in dopaminergic head 
neuron specification or differentiation, we isolated a new allele of the transcription factor HAM-1 
[HSN (Hermaphrodite-Specific Neurons) Abnormal Migration]. Loss of both HAM-1 and its target, the 
kinase PIG-1 [PAR-1(I)-like Gene], leads to abnormal dopaminergic head neuron numbers. We identified 
discrete genetic relationships between ham-1, pig-1 and apoptosis pathway genes in dopaminergic 
head neurons. We used an unbiased, quantitative mass spectrometry-based proteomics approach to 
characterise direct and indirect protein targets and pathways that mediate the effects of PIG-1 kinase 
loss in C. elegans embryos. Proteins showing changes in either abundance, or phosphorylation levels, 
between wild-type and pig-1 mutant embryos are predominantly connected with processes including 
cell cycle, asymmetric cell division, apoptosis and actomyosin-regulation. Several of these proteins 
play important roles in C. elegans development. Our data provide an in-depth characterisation of the C. 
elegans wild-type embryo proteome and phosphoproteome and can be explored via the Encyclopedia of 
Proteome Dynamics (EPD) – an open access, searchable online database.
Cellular diversity is based on the division of a cell into two unequal daughter cells; a process termed asymmetric 
cell division. Molecular mechanisms and key regulators of asymmetric cell division are conserved between ver-
tebrates and invertebrates (for review see ref. 1). Thus, the nematode C. elegans with its largely invariant devel-
opment has proven a valuable model to uncover pathways controlling asymmetric cell division. For example, 
studies into the first asymmetric cleavage of the C. elegans zygote led to the discovery of the polarity-regulating 
PAR (abnormal embryonic PARtitioning of cytoplasm) proteins, whose function is conserved in diverse animals 
(reviewed in ref. 2). In addition, a mechanistically conserved Wnt/β-catenin system resulting in unequal nuclear 
β-catenin levels in the two daughter cells has been described to act during several asymmetric divisions in C. ele-
gans (reviewed in ref. 3). Finally, the transcription factor HAM-1 (HSN Abnormal Migration) and its target, the 
conserved kinase PIG-1 (PAR-1 (I)-like Gene), were both found to regulate asymmetric cell divisions resulting in 
an apoptotic daughter cell4–6. However, it is not known either whether HAM-1 and PIG-1 interact with the PAR 
proteins and/or the Wnt/β-catenin binary system, or how such potential interactions may be regulated.
Mutation of the transcription factor HAM-1 can result in survival of daughter cells destined for apoptotic 
cell death5–7. To the best of our knowledge, the kinase PIG-1 is the only known transcriptional target of HAM-1 
involved in asymmetric cell divisions8, 9. Loss of ham-1 and pig-1 can transform the fate of daughter cells des-
tined for apoptosis and result in them developing via the same neuronal fate as their surviving sister cells7, 8. 
Furthermore, mutation of either ham-1, or pig-1, alters the resulting sizes of daughter cells: thus, in ham-1 
mutants, the normally smaller apoptotic daughter cell is larger than the sister cell. In pig-1 mutants and pig-
1;ham-1 double mutants daughter cell sizes are now similar in size5, 8. In relation to these cell size phenotypes, 
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it is interesting that HAM-1 and PIG-1 were suggested previously to regulate myosin polarisation and the posi-
tioning of the mitotic spindle9, 10, which are processes known to influence daughter cell sizes (reviewed in refs 1, 
11). However, the molecular mechanisms and proteins mediating these phenotypes that result from mutation of 
HAM-1 and PIG-1 are unknown.
PIG-1 is a member of the polarity-regulating PAR-1/Kin1/SAD-1 family of serine/threonine kinases8 and may 
play an important role in the regulation of asymmetric cell divisions. Localised phosphorylation events are known 
to contribute to the unequal segregation of cell fate determinants1 and PIG-1 expression was found at centro-
somes12 and at the cortex of adjacent cells13. The expression of PIG-1 is ubiquitous in early embryos and becomes 
progressively more restricted in older embryos and young larvae, in which PIG-1 is expressed in dividing cells8. 
In addition to its role in asymmetric cell divisions, C. elegans PIG-1 was shown to control caspase-independent 
cell death and cell shedding, a process in which cells are eliminated by being actively expelled from their sur-
rounding tissue14, 15. During cell shedding and asymmetric cell divisions, PIG-1 is controlled by the PAR-4-STRD-
1-MOP-25 complex12, 14. Furthermore, PAR-4/LKB1 was shown to act via PIG-1 to regulate myosin accumulation 
in the C. elegans one-cell embryo13. In summary, PAR-4 appears to be genetically upstream of PIG-1, but the 
downstream effectors of PIG-1 are unknown.
The mammalian orthologues of HAM-1 and PIG-1 are connected to cell cycle regulation and cell death. 
The HAM-1 orthologue, Storkhead box (STOX) protein 1, is related to forkhead box (FOX) transcription fac-
tors16, which have a conserved role in cell cycle-regulated gene expression (for review see ref. 17). Furthermore, 
STOX1 itself was found to promote mitotic entry18 and the proliferation of inner ear epithelial cells19. The PIG-1 
orthologue MELK (Maternal Embryonic Leucine zipper Kinase, also known as pEg3 kinase and MPK38) is 
predominantly expressed in proliferating cell populations and was reported to influence tumour growth and 
aggressiveness (for review see ref. 20). Putative MELK targets support a role in the regulation of cell cycle pro-
gression, cell proliferation and cell death21–31; however, the global effects of PIG-1/MELK kinase loss have not 
been investigated.
The C. elegans lineages that produce dopaminergic neurons provide a valuable system to explore the interplay 
between cell specification – a process that happens during every asymmetric cell division – and terminal cell 
differentiation – a mechanism that occurs only after the last mitotic division. C. elegans hermaphrodites possess 
8 dopaminergic neurons: 2 CEPD (CEPhalic sensilla Dorsal), 2 CEPV (CEPhalic sensilla Ventral) and 2 ADE 
(Anterior DEirid) neurons in the head and 2 PDE (Posterior DEirid) neurons in the midbody. These dopaminer-
gic neurons are derived from distinct lineages and their final differentiation is driven by a combination of dopa-
minergic ‘terminal selectors’, which are transcription factors controlling the expression of cell-specific features32, 33. 
However, the potential mechanistic connections between the HAM-1/PIG-1, PAR protein and Wnt/β-catenin 
specification pathways and subsequent dopaminergic neuron differentiation have not been characterised.
To identify factors influencing dopaminergic neuron specification and differentiation, we screened for C. ele-
gans mutants exhibiting defective dopaminergic head neurons. We isolated a new allele of ham-1 that causes an 
abnormal number of CEPD and ADE neurons and confirmed that the proposed downstream effector of ham-1, 
the kinase PIG-1, is also involved in the specification of CEPD and ADE neurons. We report epistasis between 
ham-1 and pig-1 and describe distinct genetic interactions with the apoptosis-defective mutant ced-4 (CEll Death 
abnormality) in the lineages leading to dopaminergic head neurons. Using a global and phospho-specific mass 
spectroscopy-based proteomics approach, we screened for proteins affected by PIG-1 kinase loss. We found that 
pig-1 mutation affects the abundance and phosphorylation status of key developmental proteins in the C. elegans 
embryo. In addition, we provide an in-depth characterisation of the phosphoproteome of C. elegans wild-type 
embryos. These results are accessible via the Encyclopaedia of Proteome Dynamics (EPD) − http://www.pep-
tracker.com/epd/ − a searchable, open-access online database34 providing convenient tools for developmental 
biologists to explore and visualise these complex, large-scale proteomics datasets.
Results
ham-1 mutation causes distinct defects in dopaminergic head neurons. To find genes that affect 
dopaminergic neuron development, a mutagenised population of the BY200 strain that allows for visualisation of 
C. elegans dopaminergic neurons (Pdat-1::gfp)35 was screened for defective dopaminergic head neurons. One of 
the isolated mutants, gt1984, exhibited distinct phenotypes in dopaminergic head neurons: while the number of 
ventral cephalic sensilla (CEPV) neurons was unchanged, the number of dorsal cephalic sensilla (CEPD) neurons 
was decreased and the number of anterior deirids (ADE) neurons was increased (Fig. 1a,c). Based on the largely 
invariant cell lineages of C. elegans36, 37, it can be derived that the respective ‘sister’ cells of CEPVL and CEPVR 
neurons die by apoptosis (Fig. 1d − left panels). In contrast, in the lineages of left and right CEPD and ADEL 
neurons it is an ‘aunt’ cell that becomes apoptotic (Fig. 1d − middle and right panels).
We mapped38, 39 gt1984 to the ham-1 (HSN Abnormal Migration) locus and found that the mutation com-
prises a deletion and a splice site mutation (Fig. 1b). Thus, gt1984 is expected to result in a loss-of-function 
of HAM-1, an orthologue of the Storkhead box protein 1 (STOX1) transcription factor6, 9 containing a winged 
helix DNA binding motif (Fig. 1b). We verified that the same dopaminergic head neuron defects occur in a 
second ham-1 mutant4 (Fig. 1c). While ham-1 mutants were found to exhibit dopaminergic neuron defects5, 40, 
genetic interactions in these lineages have not been described. We conclude that ham-1(gt1984) constitutes a new 
loss-of-function allele that differentially affects cell fate in dopaminergic head neuron lineages.
Apoptosis in C. elegans development is controlled by the cell death abnormality genes ced-3 and ced-4, which 
encode an executioner caspase and an Apaf1 (Apoptotic Peptidase-Activating Factor 1)-like molecule, respec-
tively41. We tested if dopaminergic head neuron specification is affected by mutation of ced-3 and ced-4 alone. 
Blinded studies showed that the number of CEPV neurons - which possess an apoptotic sister cell – is increased 
in the ced-3 and ced-4 mutants; however, the number of CEPD and ADE neurons – which possess an apoptotic 
aunt cell – is unchanged (Fig. 1e). This observation is in line with studies showing that surviving cells in either the 
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Figure 1. Distinct defects caused by ham-1 mutation and genetic interactions with the apoptosis pathway in 
the lineages leading to C. elegans dopaminergic head neurons. (a) Dopaminergic head neurons in BY200 wild-
type animals and in ham-1(gt1984) mutants. The dorsal cephalic sensilla (CEPD) neurons are located more 
posteriorly than the ventral cephalic sensilla (CEPV) neurons. A misplaced CEPD neuron is marked with an 
asterisk. (b) ham-1 gene structure with winged helix box DNA-binding domain (in white) and positions of 
mutations in ham-1(gt1984) (in orange) and ham-1(n1438) (in grey). gt1984 comprises a 554 base pair (bp) 
deletion spanning from the ham-1 promoter into the first exon and also includes a splice site mutation at the 
start of the second exon. The 238 bp deletion of the n1438 allele is within the gt1984 deletion. (c) Number 
of dopaminergic head neurons in BY200 wild-type and ham-1 mutant animals. Error bars = SEM of 2−4 
biological replicates with 50 animals each. (d) Cartoon depicting the last divisions in the cell lineages that 
produce C. elegans dopaminergic head neurons (dopaminergic neurons are indicated with a solid black circle): 
left and right ventral cephalic sensilla neurons (CEPVL/R), left and right dorsal cephalic sensilla neurons 
(CEPDL/R) and left and right anterior deirids neurons (ADEL/R). Cells undergoing developmental apoptosis 
are marked with a cross. Daughter cells resulting from an anteroposterior division are labelled with ‘a’ and ‘p’, 
respectively, while daughter cells resulting from a left-right division are labelled with ‘l’ and ‘r’, respectively, 
starting from the ‘AB’ precursor cell. (e) Number of dopaminergic head neurons in the ham-1 mutant, in the 
apoptosis pathway mutants ced-3 and ced-4 and in the ced-4;ham-1 double mutant. Error bars = SEM of 2−4 
biological replicates with 50 animals each.
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ced-3 or ced-4 mutants can adapt sister cell fates, but do not divide further to produce differentiated cells5, 41, 42. 
Moreover, we found that mutation of ham-1 in the apoptosis-deficient background did not result in a further 
increase in CEPV neuron numbers (Fig. 1e – left panel). Therefore, the prevention of cell death appears to be 
sufficient to transform the normally apoptotic sisters into additional CEPV neurons.
Cell fate transformations caused by mutation of ham-1 can be masked by cell death5–7. If this is true for the 
dopaminergic head neuron lineages, the lower number of CEPD neurons in the ham-1 mutant is expected to 
be reversed in an apoptosis-deficient mutant background. Indeed, we found that in the ced-4;ham-1 double 
mutant CEPD neuron numbers are either restored to wild-type levels, or are even higher (Fig. 1e – middle panel). 
However, the already increased number of ADE neurons in the ham-1 mutant was not altered by additional 
mutation of ced-4 (Fig. 1e – right panel). Hence, ham-1 leads to cell fate transformations in both CEPD and ADE 
neurons, however in CEPD neurons the transformed cells appear to die via apoptosis.
pig-1 genetically interacts with ham-1 to specify dopaminergic neurons. If PIG-1 is a general 
HAM-1 effector, pig-1 and ham-1 mutants are expected to show similar dopaminergic neuron defects. To deter-
mine pig-1 mutant phenotypes, we used pig-1(gm344), which likely represents a null allele (Fig. 2a). We found 
that both pig-1(gm344) single mutants and pig-1;ham-1 double mutants exhibited a wild-type number of CEPV 
neurons. Thus, CEPV neurons are not affected by loss of ham-1 and pig-1 (Fig. 2b – left panel). Furthermore, pig-
1 mutants show a higher number of ADE neurons, similar to ham-1 mutants and pig-1;ham-1 double mutants 
(Fig. 2b – right panel). Hence, pig-1 and ham-1 appear to repress ADE cell fate via a similar mechanism. However, 
in contrast with ham-1 mutants, pig-1 mutants did not display an decreased number of CEPD neurons (Fig. 2b 
– middle panel and ref. 8) and mutation of pig-1 rescued the reduced number of CEPD neurons in the ham-1 
mutant (Fig. 2b – middle panel). Therefore, pig-1 acts as a suppressor of neuronal fate in both CEPD and ADE 
lineages and is epistatic to ham-1 in CEPD neurons.
We next tested genetic interactions between pig-1 and the ced-4 apoptosis gene in dopaminergic neuron line-
ages. We found that CEPD neuron numbers were higher in the ced-4;pig-1 double mutant, even though ced-4 and 
pig-1 single mutants did not exhibit a phenotype (Fig. 2c – middle panel). This synergism is likely caused by the 
unmasking of a cell fate conversion in the apoptosis-deficient background, as is the case for ham-1 and ced-4 in 
CEPD neurons (Fig. 1e). In contrast, the higher number of CEPV neurons in the ced-4 mutants was not further 
increased by mutation of pig-1 (Fig. 2c – left panel). Also, the higher number of ADE neurons in the pig-1 mutants 
was not further increased by mutation of ced-4 (Fig. 2c – right panel). These results show that only one of the 
three lineages leading to dopaminergic head neurons shows a synergistic genetic relationship between pig-1 and 
the apoptosis pathway as reported for other C. elegans lineages8. We further examined the phenotype of the ced-
4;pig-1;ham-1 triple mutant and found that in the ADE neuron lineage – in contrast to the CEPV and CEPD neu-
ron lineages – mutation of ced-4 did not lead to higher dopaminergic neuron numbers than in the ham-1;pig-1 
mutant background (Fig. 2d). In summary, we report varying genetic interactions between ham-1, pig-1 and ced-4 
in the distinct dopaminergic head neuron lineages.
Changes in protein abundance and signalling pathways in the pig-1 mutant. To identify proteins 
and pathways that are affected by loss of the PIG-1 kinase, we turned to an unbiased, mass spectrometry-based 
proteomics approach (Fig. 3a). We aimed to determine PIG-1 targets in ‘late’ C. elegans embryos, corresponding 
to the developmental time point at which the last cell divisions of the dopaminergic head neuron lineage take 
place. Thus, we compared the proteomes and phosphoproteomes of wild-type and pig-1 mutant embryos that 
were left to develop for 4 hours at 20 °C after isolation from a synchronised population of adult C. elegans her-
maphrodites. Since PIG-1, which is an AMP-activated protein kinase-related protein, is likely to form part of a 
kinase cascade, we anticipate that both direct and indirect PIG-1 targets will be differentially phosphorylated in 
the pig-1 mutant. In addition, proteins participating in pathways affected by pig-1 mutation might also exhibit 
altered protein abundances. To facilitate interactive exploration of these large, complex datasets, the resulting 
protein abundance and protein phosphorylation data from the analysis of wild-type and pig-1 mutant embryos 
described below, were incorporated into the Encyclopedia of Proteome Dynamics (EPD) database (Fig. 3b).
In the 5% of each peptide fraction that was used to measure protein abundance, we detected 51,414 unique 
peptides for wild-type and 48,690 unique peptides for the pig-1 mutant, across the three biological replicates 
(Supplementary Table 1a). Peptides that were detected in at least two out of the three biological replicates were 
mapped to a total of 6,449 proteins for wild-type and 6,104 proteins for the pig-1 mutant, respectively. Of these 
proteins, 184 were found to be >2-fold upregulated and 113 > 2-fold downregulated in pig-1 mutant embryos, as 
compared with wild-type embryos, in at least two out of the three replicates (p-value < 0.05; false discovery rate 
(FDR) < 5% for both peptide and protein identification) (boxed in Fig. 4a) (Supplementary Table 2).
To investigate whether pig-1 mutation alters the abundance of proteins associated with specific biological pro-
cesses, we analysed the Gene ontology (GO) term annotations associated with both the down- and upregulated 
proteins detected (Supplementary Table 5a,b). GO terms associated with downregulated proteins encompass 
myosin-regulation (‘striated muscle myosin thick filament assembly’, ‘muscle contraction’), locomotion (‘locomo-
tion’, ‘inductive cell migration’) and metabolism (‘protein catabolic process’, ‘growth’, ‘cellular amino acid biosyn-
thetic process’ and ‘metabolic process’) (Fig. 4b). An increase in abundance was observed for proteins linked to 
cell cycle regulation (‘DNA replication’, ‘cell cycle’, ‘cell division’, ‘mitotic spindle organisation’), embryo develop-
ment, apoptosis (Fig. 4c) and microtubule regulation (Supplementary Table 5b). We conclude that pig-1 mutation 
leads to an overall decrease of proteins related to actomyosin processes, locomotion and metabolism and to an 
overall increase of proteins connected to the cell cycle, embryo development, apoptosis and microtubules.
We next examined selected proteins within these highlighted biological processes showing altered protein 
abundances in pig-1 mutant embryos. The selected proteins connected to either cell cycle regulation (Fig. 5a), 
or microtubule organisation (Fig. 5b), were more abundant in the pig-1 mutant than in wild-type embryos. In 
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contrast, selected proteins connected to actomyosin regulation were downregulated: For example, we detected a 
>5-fold lower protein abundance (note the logarithmic scale in Fig. 5) of MLC-3 (myosin light chain), MYO-1 
(myosin heavy chain structural genes), MYO-2, MYO-4, MYO-5 and MYO-6 (Fig. 5c).
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Figure 2. pig-1 is epistatic to ham-1 in the CEPD neuron lineage and genetically interacts with the apoptosis 
pathway. (a) pig-1 gene structure with position of the predicted kinase and kinase-associated domains (both 
in white) and the pig-1(gm344) 562 bp deletion (in green). In gm344, 400 bp of the pig-1 promoter and the first 
132 bp of the kinase domain are deleted. (b) Number of dopaminergic head neurons in the ham-1, pig-1 and 
pig-1;ham-1 mutant. (c) Number of dopaminergic head neurons in the pig-1, ced-4 and ced-4;pig-1 mutant. 
(d) Number of dopaminergic head neurons in the double and triple mutants of ham-1, pig-1 and ced-4. Error 
bars = SEM of 2–4 biological replicates with 50 animals each.
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Next, we examined protein abundance changes in pathways previously connected to pig-1 phenotypes. We 
found that proteins associated with asymmetric cell division, such as the centralspindlin complex-forming 
ZEN-4 (Zygotic epidermal ENclosure defective) and CYK-4 (CY to Kinesis defect) (reviewed in ref. 44), were 
more abundant in pig-1 mutant embryos (Fig. 5d). Further examples include the >3.5-fold higher abundances 
detected for GPR-2 (G Protein Regulator) and LIN-5 (abnormal cell LINeage), the orthologues of Drosophila 
PINS (Partner of INScuteable) and NuMA (Nuclear Mitotic Apparatus protein), respectively. GPR-2 and LIN-5 
mediate the formation of differently sized daughter cells via microtubule-cortex interactions in the C. elegans 
one-cell embryo (for review see ref. 1). We also observed that Wnt signalling components, such as the Wnt recep-
tor MOM-5 (MOre of MS) and DSH-2 (DiSHevelled related), showed higher abundance in pig-1 mutant embryos 
(Fig. 5d). Furthermore, as pig-1 genetically interacts with the apoptosis pathway (Fig. 2c, refs 8, 14, 15) and as 
pig-1 was suggested to promote the digestion of apoptotic cells14, we examined proteins related to cell death and 
corpse engulfment. We found that the apoptosis proteins CED-3 and CED-4 and the corpse engulfment proteins 
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modification (PTM) data from wild-type and pig-1 mutant embryos available in the Encyclopedia of Proteome 
Dynamics (EPD).
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Figure 4. Global protein abundance changes in pig-1 mutant embryos. (a) Volcano plot (in log10 vs. log2 scale) 
depicting protein abundance changes in the pig-1 mutant embryo compared to wild-type embryos. The dashed 
orange and red lines indicate a p-value of 0.05 and 0.01 (1.3 and 2 in log10 scale), respectively. Boxed proteins 
were at least 2-fold down- or upregulated with a p-value of 0.05 and used for gene ontology term analysis. An 
interactive version of this volcano plot is available online via the EPD. To illustrate its functions, several proteins 
are highlighted and for one of them a tooltip with further available information is displayed. (b and c) Gene 
ontology term (GO) enrichment (biological process) of pig-1-variant proteins (boxed in the volcano plot). x and 
y-axis indicate semantic space used to group GO terms of related biological processes. Bubble sizes indicate the 
frequency of the GO term in the underlying C. elegans protein database (larger bubbles reflect more common 
terms) and bubble colour indicates statistical significance (the greener, the lower the p-value). (b) GO term 
analysis of proteins with at least 2-fold downregulated abundance in the pig-1 mutant (Supplementary Table 5a). 
(c) GO term analysis of proteins with at least 2-fold upregulated abundance in the pig-1 mutant (Supplementary 
Table 5b).
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CED-2 and CED-12, all show increased abundance in pig-1 mutant embryos (Fig. 5e). We also detected altered 
abundances of several cell adhesion proteins in pig-1 mutant embryos (Fig. 5f). These data support the reported 
function of PIG-1 in cell detachment (‘shedding’) by interfering with the cell-surface expression of cell adhesion 
proteins in C. elegans caspase-deficient embryos14. PIG-1-mediated cell shedding was suggested to involve endo-
cytosis14. Consistent with this proposal, we found that the vesicle trafficking protein ARF-1.2 (ADP-Ribosylation 
Factor-related), which is required for cell shedding14, was downregulated in pig-1 mutants, while the abundance 
of other vesicle trafficking proteins was upregulated (Fig. 5g).
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Figure 5. Abundance changes of key pathway proteins in pig-1 mutant embryos. Proteins exhibiting a 
significantly different abundance (in log2 scale) in pig-1 mutant embryos as compared to wild-type embryos, 
in at least two out of the three biological replicates (p-value < 0.05, two-tailed t-test; FDR < 5%) (replicate 
values are indicated in black and the calculated average over the replicates is indicated in red). Proteins are 
grouped according to their functional association with. (a) cell cycle regulation, (b) microtubule regulation, 
(c) actomyosin regulation, (d) asymmetric cell division, (e) cell death or phagocytosis, (f) cell adhesion, or (g) 
vesicle trafficking.
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Mutation of the PIG-1 kinase leads to phosphorylation changes in key development path-
ways. We hypothesised that both direct and indirect targets of the PIG-1 kinase may exhibit altered pro-
tein phosphorylation levels in pig-1 mutant embryos. To test this hypothesis, we compared phosphopeptide 
abundances in pig-1 mutant and wild-type embryos. Using a phosphopeptide enrichment step prior to liquid 
chromatography-mass spectroscopy analysis (Fig. 3a), we detected 7,247 phosphosites in wild-type embryos 
and 7,913 phosphosites in pig-1 mutant embryos across the three biological replicates (FDR < 5%, localisation 
probability ≥75%) (Fig. 6) (Supplementary Table 1b). To facilitate the convenient exploration of this complex 
phosphoproteomics dataset, we created an interactive, searchable version of the data summarised in Fig. 6, which 
is available online via the EPD (http://www.peptracker.com/epd/). The plot features a custom visualisation tool 
that allows every phosphorylation site we identified to be selected and traced through a set of cognate metadata. 
We provide information about the abundance of each selected protein and its phosphosites, the amino acid posi-
tion of each phosphosite in the protein, statistical evaluation of biological replicates, as well as linking to the raw 
mass spectrometry files. For wild-type embryos, these phosphosites correspond to 1,925 phosphorylated proteins 
(localisation probability ≥75%) (Supplementary Table 1b, Supplementary Table 3). To the best of our knowledge, 
this is the first dataset describing global protein phosphorylation in C. elegans embryos.
To help evaluate the significance of differences in the phosphoproteomes of pig-1 mutant and wild-type 
embryos, we aimed to determine the stoichiometry of phosphorylation in relation to protein abundance. For this, 
we compared pig-1/wild-type phosphopeptide abundances to the corresponding pig-1/wild-type protein abun-
dances (Fig. 7a). This showed that most proteins are located within two standard deviations of the diagonal of the 
plot, indicating that changes in phosphosite abundance tally with changes in protein abundance. Thus, these pro-
teins are not significantly changing their stoichiometry of phosphorylation. However, proteins located more than 
two standard deviations from the mean were considered strong candidates for being differentially phosphorylated 
in the pig-1 mutant, as compared with wild-type, embryos (Supplementary Table 4a). In addition to the differ-
entially phosphorylated proteins, we identified 220 proteins that were exclusively phosphorylated in wild-type 
embryos and 288 proteins that were only phosphorylated in pig-1 mutant embryos (Fig. 7b) (Supplementary 
Table 4b,c). The GO terms associated with proteins harbouring the respective up- and downregulated phos-
phosites were similar and connected to embryo development, the cell cycle and apoptosis (Fig. 7c,d). We note 
that this similarity in the biological processes connected with either increased, or decreased, levels of phospho-
rylation contrasts with our earlier finding that distinct processes were associated with the proteins showing either 
increased, or decreased abundance (Fig. 4b,c). In summary, we find that pig-1 mutation leads to differential phos-
phorylation of multiple proteins associated with key developmental processes.
Next, we examined the phosphorylation of selected proteins groups associated with changes in either protein 
abundance, or protein phosphorylation levels, in pig-1 mutant embryos, as determined by GO term analysis. As 
seen in the phosphosite GO term analysis (Fig. 7e,f), pig-1 mutation differentially affects phosphorylation of pro-
teins mediating similar processes (Fig. 8). For example, phosphorylation of S80 in the cell division cycle protein 
CDC-25.2 was only detected in wild-type embryos, while phosphorylation of CDC-5L T377 was only detected in 
pig-1 mutants (Fig. 8a). Furthermore, phosphorylation of S58 and T530 in the DNA replication protein MCM-10 
[yeast MCM (licensing factor) related] is only detected in pig-1 mutant embryos, while phosphorylation of ICP-1 
(INCENP (inner centromere protein) homolog) is decreased at least 10-fold at 4 different sites (Fig. 8a) (note 
logarithmic scale in Fig. 8).
We found that pig-1 mutation affects the phosphorylation of proteins previously associated with pig-1 func-
tion. PIG-1 was shown to regulate the localisation of NMY-2 (Non-muscle MYosin)9, 10, 13 and NMY-2 itself affects 
the asymmetric distribution of several polarity proteins in the C. elegans one-cell embryo1. We found that in pig-1 
mutant embryos, NMY-2 S211 and S1974 are ~8-fold and ~10-fold less phosphorylated (Fig. 8c). In addition, 
PIG-1 was shown to control myosin accumulation in a pathway parallel to ANI-1 [ANIllin (actin-binding pro-
tein)]13 and we found that ANI-1 S352 is over 8-fold and ANI-1 T486 over 40-fold less phosphorylated in pig-1 
mutants (Fig. 8d). Furthermore, when investigating apoptotic corpse engulfment proteins, we found that CED-1 
S1050 and CED-8 S411 are only phosphorylated in wild-type animals (Fig. 8e).
PIG-1 was suggested to affect the expression of cell adhesion proteins14 and we found that AJM-1 (Apical 
Junction Molecule) S766 and DLG-1 (Drosophila Discs LarGe homolog) S161 and S471 exhibit increased phos-
phorylation in pig-1 mutant embryos (Fig. 8f). DLG-1 is a MAGUK (membrane-associated guanylate kinase) 
protein that mediates a microtubule-dependent pathway important for the segregation of cell fate determinants in 
Drosophila (reviewed in ref. 1). Furthermore, the inappropriate cell-surface expression of cell-adhesion molecules 
in pig-1 mutants was proposed to be based on impaired endocytosis14, a process that appears to play an important 
role in asymmetric cell division1. We found increased phosphorylation for several endocytosis-associated pro-
teins in pig-1 mutant embryos (Fig. 8g).
Lastly, we found that pig-1 mutation also affects the phosphorylation status of proteins connected to asym-
metric cell division. PAR-3 (abnormal embryonic PARtitioning of cytoplasm) for example, the C. elegans ortho-
logue of Drosophila Bazooka, exhibits decreased phosphorylation of S1032 (Fig. 8d). pig-1 mutation also leads to 
altered phosphorylation of MEX-5 (Muscle EXcess), MEX-6 and PLK-1 (POLO Kinase) (Fig. 8d), proteins that 
segregate into the anterior daughter cell and help to establish the correct division of the C. elegans one-cell embryo 
(reviewed refs 1, 45). Furthermore, we found that phosphorylation of DSH-1 S904 is only detected in pig-1  
mutants (Fig. 8d). Dishevelled proteins are Wnt pathway components and normally enriched at the posterior part 
of an asymmetrically dividing cell3.
To provide the research community with convenient access to the results from this study, all the proteomics 
data describing protein and phosphopeptide abundance changes in the pig-1 mutant embryos, as well as phos-
phopeptide detection in C. elegans wild-type embryos, have been incorporated in the Encyclopaedia of Proteome 
Dynamics (EPD) − http://www.peptracker.com/epd/. The EPD currently includes the largest collection of anno-
tated, searchable mass spectrometry-based proteomics data from studies in C. elegans, linked with other extensive 
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Figure 6. Phosphosites detected in wild-type and pig-1 mutant embryos. (a) Detected protein post translational 
modification (PTM) phosphorylation sites in wild-type embryos. Each grey line represents a phosphorylation 
site and models its behaviour across multiple dimensions. The phosphorylation lines intersect the y-axes on 
the values that were detected for the specific site. The axis dimensions are ‘modified amino acid’ (threonine 
(T), serine (S) or tyrosine (Y)), ‘protein intensity’ (in log10 scale), ‘site intensity’ (in log10 scale), ‘PTM site 
probability’, ‘position in protein’ (in log10 scale), ‘score’ (of identification, the product of all peptide posterior 
error probabilities used for identification that is calculated in MaxQuant), and number of ‘replicates with data’. 
(b) Detected protein phosphorylation sites of two example proteins in pig-1 mutant embryos - the grey lines for 
background phosphorylation were removed in this graph. Both of these plots are available online as interactive 
visualisations via the EPD (http://www.peptracker.com/epd/). Firstly, the axes can be filtered such that only 
elements contained within the user-defined boxes are shown: in the depicted graphs an example filter of ≥0.75 
was applied for the ‘PTM site probability’ axis. Secondly, proteins can be searched and their phosphorylation 
sites can be highlighted in colour: Here, this was done for the same two example proteins and the search bar is 
shown on top of one of the graphs. Thirdly, selection of a phosphorylation line will lead to the display of a tooltip 
box containing further information: In the graphs shown, this was done for three examples of phosphorylation 
sites.
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Figure 7. Global phosphoproteome changes in pig-1 mutant embryos. (a) Phosphorylation site abundance 
ratio (pig-1/wild-type) compared to protein abundance ratio (pig-1/wild-type). The orange dotted line indicates 
where the phosphorylation site ratio is equal to the protein ratio. Points within the orange and red areas 
are within one and two standard deviations from equality, respectively. An interactive version of this plot is 
accessible online via the EPD. In this illustration, detected phosphorylation sites for three example proteins 
were marked and a tooltip containing further information is shown for one of these phosphorylation sites. (b) 
Number of phosphorylated proteins detected either in wild-type (red) or in pig-1 mutant embryos (blue) or 
in both genetic backgrounds (purple overlap)(localisation probability >75%). (c and d) Gene ontology (GO) 
term enrichment (biological process) of pig-1 variant phosphosites. x- and y-axis indicate semantic space 
used to group GO terms of related biological processes. Bubble sizes indicate the frequency of the GO term 
in the underlying C. elegans protein database (larger bubbles reflect more common terms) and bubble colour 
indicates statistical significance (the greener, the lower the p-value). (c) GO term analysis of downregulated 
phosphosites in the pig-1 mutant (related to Supplementary Table 5c). Phosphosites downregulated in pig-1 
(outside of the 2 standard deviation range in (a)) were pooled with phosphosites that were only detected in 
wild-type embryos (red in (b)). (d) GO term analysis of phosphosites with upregulated abundance in the pig-1 
mutant (Supplementary Table 5d). Phosphosites upregulated in pig-1 mutant embryos (outside of the 2 standard 
deviation range in (a)) were pooled with the phosphosites that were only detected in pig-1 mutant embryos 
(blue in b)).
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Figure 8. Phosphopeptide abundance changes of key pathway proteins in pig-1 mutant embryos. Ratio of 
phosphopeptide abundance and protein abundance (in log2 scale) in pig-1 mutants as compared to wild-type 
embryos (white diamonds). Phosphosites that were only detected in either pig-1 mutants (blue diamonds), 
or wild-type embryos (red diamonds), are shown above and below the y-axis, respectively. Proteins are 
grouped according to their functional association with (a) cell cycle regulation, (b) microtubule regulation, 
(c) actomyosin regulation, (d) asymmetric cell division, (e) cell death or phagocytosis, (f) cell adhesion, or (g) 
vesicle trafficking.
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data sets from studies on human cells and model organisms. In addition, the corresponding raw mass spectrom-
etry data files are freely available via the PRIDE repository, a partner in the ProteomXchange Consortium (http://
proteomecentral.proteomexchange.org/).
Discussion
We report that the transcription factor HAM-1 and the kinase PIG-1 have a role in the specification of C. elegans 
dopaminergic head neurons. ham-1 and pig-1 appear to be required for asymmetric cell divisions that result in 
an apoptotic daughter cell and either a neuron, or a neuronal precursor5, 6, 8, 9. In the case of dopaminergic head 
neurons, the last cell division in the CEPVL/R neuron lineages and the second last division for the CEPDL/R and 
ADEL/R neuron lineages, are the first ones to directly produce such an apoptotic daughter cell (Fig. 1d, http://
wormweb.org/celllineage). We therefore consider it likely that ham-1 and pig-1 affect the asymmetric division of 
these neuroblasts. Genetic interactions in the CEPD lineage support that mutation of ham-1 and pig-1 might lead 
to sister-sister cell fate conversions, thereby turning a normally apoptotic aunt cell into a dopaminergic neuron 
precursor cell. When blocking cell death by mutation of the apoptosis pathway gene ced-4, these conversions are 
unmasked and result in higher neuron numbers. In addition, our experiments support that the genetic interaction 
between ham-1 and pig-1 depends on the exact neuronal lineage analysed. pig-1 was implicated as a transcrip-
tional target and HAM-1 effector in the Q.a neuroblast9. Consistent with this, we find an increased number of 
ADE neurons in ham-1 and pig-1 single and double mutants. In contrast, the reduced number of CEPD neurons 
observed in ham-1 mutants is supressed by pig-1.
A key feature of this study was the use of a combination of quantitative, mass spectrometry-based proteomic 
and phosphoproteomic analyses to provide an in-depth, unbiased characterisation of the global changes that 
occur after genetic disruption of the PIG-1 kinase in C. elegans embryos. Direct targets of the PIG-1 kinase are 
expected to exhibit lower abundance of phosphorylated peptides in pig-1 mutants, as compared with wild-type 
embryos. However, by analysing overall protein phosphopeptide and protein abundance changes, we were also 
able to measure indirect effects of pig-1 inactivation. The extent of differential phosphorylation between wild-type 
and pig-1 mutant embryos suggests that the majority of detected phosphorylation sites affected may not depend 
on direct phosphorylation by PIG-1 kinase. We note that this is the first study to analyse the effects of a kinase 
mutation on the global phosphoproteome in C. elegans.
In addition to the comparison of wild-type and pig-1 mutant embryos described above, this study represents 
the first global phosphoproteome analysis reported for C. elegans embryos. We identify 5,051 phosphosites, cor-
responding to 1,639 phosphorylated proteins, in C. elegans wild-type embryos, which are detected in at least two 
out of the three biological replicates (FDR < 5%, localisation probability >75%) (Supplementary Table 1b). In 
addition, we detect 288 proteins that are only phosphorylated in pig-1 mutant embryos (Supplementary Table 4c). 
There are only a limited number of phosphoproteome studies in C. elegans, reporting the identification of 
~6,80046, ~6,50047 and ~3,50048 phosphorylation sites, respectively, in adult animals. However, our dataset is the 
first to identify phosphosites in the embryo and thus represents a valuable resource for the investigation of C. ele-
gans development. Comparison with the C. elegans dataset from PhosphoPep48, a protein phosphorylation data-
base for model organisms, showed that ~50% of the phosphosites we detect in embryos are novel (Supplementary 
Table 6).
We found that mutation of the PIG-1 kinase preferentially affected proteins associated with the cell cycle and 
asymmetric cell division, supporting the idea that PIG-1 might regulate the timing of cell cycle events in the 
neuroblast and thereby influence neuroblast polarity8. We note that cell division, cell polarity and differentiation 
are all tightly coordinated during animal development (reviewed in refs 49, 50). In addition, our results indicate 
that PIG-1 influences proteins regulating myosin distribution and spindle positioning. These processes are known 
to influence asymmetric cell divisions (for review see refs 1, 11) and might thus provide clues as to why pig-1 
mutants exhibit daughter cells of approximately equal size. Finally, microtubule-associated proteins are more 
abundant and differentially phosphorylated in pig-1 mutants. During asymmetric cell divisions, microtubules 
maintain the established cell polarity by mediating interactions between centrosomes and the cell cortex1, 11. 
Therefore, the affected candidate proteins offer a promising starting point for further research.
The mammalian PIG-1 homologue, MELK, has also been implicated in cell cycle regulation21, 27–30. For exam-
ple, MELK was shown to phosphorylate the mitosis-promoting phosphatase CDC25B that promotes transition 
to mitosis21. Since MELK overexpression blocks the transition to mitosis21, 29, 51, CDC25B phosphorylation by 
MELK is assumed to be inhibitory and mutation of the MELK kinase is therefore expected to stimulate cell divi-
sion. Moreover, MELK overexpression has been associated with tumour growth and aggressiveness (for review 
see ref. 20).
In summary, the data presented here provide important new insights into the regulatory processes and signal-
ling events involving PIG-1 that control asymmetric cell division during neuronal differentiation in C. elegans. In 
addition, this first detailed phosphoproteomic analysis of C. elegans embryos, together with the new interactive 
data visualisation tools we have developed, provide a valuable resource for developmental biologists studying 
both C. elegans and other species.
Methods
C. elegans strains and maintenance. TG2435 Bristol, a backcrossed version of BY20035, was used as 
the wild-type strain. TG4200 (ham-1(gt1984) IV;vtIs1 V) was isolated following ethyl methanesulfonate (EMS)-
mutagenesis and backcrossed six times. Worms were maintained at 20 °C on nematode growth medium (NGM) 
plates seeded with E. coli strain OP50.
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Strains. BY200 vtIs[pdat-1::gfp;rol-6] V
TG2435 vtIs[pdat-1::gfp;rol-6] V
TG4200 ham-1(gt1984) IV;vtIs1 V
TG4201 ham-1(n1438) IV;vtIs1 V
TG4202 ced-3(n717);vtIs1 V
TG4203 ced-4(n1162);vtIs1 V
TG4204 ced-4(n1162);ham-1(gt1984) IV;vtIs1 V
TG4205 pig-1(gm344) IV;vtIs1 V
TG4206 pig-1(gm344) IV; ham-1(gt1984); vtIs1 V
TG4207 ced-4(n1162) III; pig-1(gm344) IV;vtIs1 V
TG4208 ced-4(n1162) III; pig-1(gm344) IV; ham-1(gt1984); vtIs1 V
Microscopy. For live imaging of neurons, L4 stage and young adult C. elegans hermaphrodites were placed in 
a drop of 20 mM levamisole on a slide containing an agar pad. A 1.5 mm cover slip was then placed on each slide 
and animals were imaged with a DeltaVision microscope. Quantification was performed blind with a Zeiss Axio 
Scope microscope.
Mass spectrometry. Protein extraction and digest. For protein extraction, twelve 9 cm plates containing a 
synchronised population of C. elegans gravid hermaphrodites (ca. 40,000 animals) were washed to remove already 
laid eggs. The unlaid eggs were collected by bleaching and let develop for 4 hours at 20 °C before adding 500 μL of 
lysis buffer (8 M urea in 100 mM triethyl ammonium bicarbonate (TEAB) pH 8.5). The C. elegans embryos were 
then flash-frozen in liquid nitrogen and stored at −20 °C. The samples were ultrasonicated using a Bioruptor 
(30 cycles: 30 sec on, 30 sec off), reduced using tris(2-carboxyethyl)phosphine (TCEP) (25 mM) for 30 minutes 
at room temperature, then alkylated in the dark for 30 minutes using 2-iodoacetamide (50 mM). Total protein 
was quantified using the EZQ assay (Life Technologies). The lysates were diluted with 100 mM TEAB 4-fold for 
the first digestion with endoprotease Lys-C (Wako), then further diluted 2.5-fold before a second digestion with 
trypsin. Lys-C and trypsin were used at an enzyme to substrate ratio of 1:50 (w/w). The digests were carried out 
overnight at 37 °C, then stopped by acidification with trifluoroacetic acid (TFA) to a final concentration of 1% 
(v/v).
Peptide desalting and solid phase extraction. Prior to fractionation, the protein digests were desalted using C18 
Sep-Pak Cartridges (Waters). Cartridges were first activated with Acetonitrile (ACN) and equilibrated with 50% 
ACN in water according to the manufacturer’s protocol. The samples were loaded and washed 4 times with 500 μL 
water containing 0.1% TFA. The peptides were eluted into a fresh Eppendorf tube with 800 μL 50% ACN and then 
dried in vacuo.
Off-line HILIC fractionation. Hydrophilic interaction chromatography (HILIC) was performed on a Dionex 
UltiMate 3000 (Thermo Scientific) using a similar protocol to the method described previously52–54. The dried 
peptides were redissolved in 80% ACN incorporating 0.1% TFA. The peptides were resolved on TSK-gel amide 
80- column (TOSOH) using an inverted organic gradient of solvent A (water, 0.1% TFA) and solvent B (ACN, 
0.1% TFA). 24 fractions were collected in 96-well deep well plates.
Phosphopeptide enrichment. Phosphopeptide enrichment was carried out on the HILIC fractions with titanium 
IMAC (immobilised metal affinity chromatography) beads (MagReSyn) using the original protocol by Larsen 
et al.43 on an automated bead processing robot (KingFisher, Thermo Fisher Scientific) as described in Tape et al.55. 
The enriched phosphopeptide fractions were dried, redissolved in 5% formic acid and analysed in data-dependent 
mode on Q Exactive Plus Orbitrap mass spectrometer (Thermo Fisher Scientific).
Liquid chromatography electrospray tandem mass spectrometry analysis (LC-ES-MS/MS). 5% of the material was 
analysed using a Q Exactive Plus Orbitrap mass spectrometer (Thermo Fisher Scientific) equipped with a Dionex 
ultra high-pressure liquid chromatography system (nano RSLC) without enrichment in order to quantify changes 
in protein expression levels. RP-LC was performed using a Dionex RSLC nano HPLC (Thermo Scientific). 
Peptides were injected onto a 75 μm × 2 cm PepMap-C18 pre-column and resolved on a 75 μM × 50 cm reverse 
phase-C18 EASY-Spray temperature-controlled integrated column-emitter (Thermo Fisher Scientific) using a 
four hour multistep gradient from 5% B to 35% B with a constant flow of 200 nL/min. The mobile phases were: 
2% ACN incorporating 0.1% FA (Solvent A) and 80% ACN incorporating 0.1% FA (Solvent B). The spray was 
initiated by applying 2.5 kV to the EASY-Spray emitter and the data were acquired under the control of Xcalibur 
software in a data-dependent mode.
95% of the material was subject to phosphopeptide enrichment and analysed on a Q Exactive Plus using a two 
hour gradient.
Database searching and protein quantification. The raw mass spectrometry data were processed using the 
MaxQuant software suite (version 1.5.2.8). Proteins and peptides were identified using the UniProt C. elegans 
reference proteome database (Swiss-Prot and Trembl separately), using the Andromeda search engine56, 57 with 
the following search parameters: carbamidomethylation of cysteines was defined as a fixed modification, while 
methionine oxidation, acetylation of N-termini of proteins, conversion of glutamine to pyro-glutamate and phos-
phorylation on STY were set as variable modifications. The false discovery rate was set to 5% for proteins and 
peptides.
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Mass spectrometry data analysis. The volcano plot depicting protein abundances was generated based on the 
label-free quantification intensity of proteins present in at least two of the three biological replicates in wild-type 
and mutant embryos. Statistical significance was determined with a two-tailed Student’s t-test with a randomisa-
tion setting fixed at 250 on the Perseus software platform58. For phosphorylation site analysis, data analysis was 
performed in Python using the scipy statistical package. Only phosphosites with a localisation site probability 
higher than 75% and a score higher than 40 were considered. Elements present in both wild-type and pig-1 
mutant embryos were added to the phosphosite comparison analysis, while elements present in only one of the 
genotypes were separated into two genotype-specific output files and visualisations. In the comparison analysis, 
the mutant over wild-type phosphosite abundance and protein abundance ratios were calculated and converted 
into log2 format for visualisation purposes. In the genotype-specific analysis, a log10 transformation was applied 
to the protein intensity, phosphorylation site intensity and the position of the post-translational modification 
within the protein to render the visualisation more user-friendly. The visualisation is presented in D3.js and the 
data is stored in Cassandra.
Data depository. Data generated in this study is accessible via the Encyclopaedia of Proteome Dynamics (EPD)34 
(http://www.peptracker.com/epd/) for convenient exploring and display. In addition, the raw mass spectrome-
try files as well as the MaxQuant output have been deposited to the ProteomeXchange Consortium (http://pro-
teomecentral.proteomexchange.org) via the PRIDE59 partner repository with the dataset identifier PXD005752.
Gene ontology term analysis. Gene ontology (GO)-term enrichment analysis was performed with the DAVID 
functional annotation tool (https://david.ncifcrf.gov/)60, 61. The complete list of C. elegans proteins detected in 
mass spectrometry-based proteomics was used as background and the GO term subcategories ‘GOTERM_BP_
DIRECT’ ‘GOTERM_CC_DIRECT’ and ‘GOTERM_MF_DIRECT’ selected for analysis. The results were ana-
lysed with REVIGO62 and plotted using the provided R script to remove GO term redundancy. In REVIGO, 
p-values were provided and the C. elegans database and the SimRel semantic similarity measure were used for 
analysis. A ‘medium’ REVIGO list size was selected.
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